# US Veterinary Artificial Insemination Market > US Veterinary Artificial Insemination Market Research Report: Size, Share, Trend Analysis By Product Type (Equipment, Reagents & Kits, Others) and By End Users (Veterinary Hospitals, Veterinary Clinics, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.41% - **2024:** $ 1,334.23 Million - **2025:** $ 1,433.1 Million - **2035:** $ 2,929.24 Million - **Key Players:** Genus plc (GB), Zoetis Inc. (US), Merck Animal Health (US), Heska Corporation (US), Neogen Corporation (US), CooperSurgical Inc. (US), Vetoquinol S.A. (FR), Boehringer Ingelheim (DE), Allflex Livestock Intelligence (AU) **Report ID:** MRFR/HC/15140-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-veterinary-artificial-insemination-market-16668 --- ## Market Summary ## **US Veterinary Artificial Insemination Market Overview** As per MRFR analysis, the US Veterinary Artificial Insemination Market Size was estimated at 1.25 (USD Billion) in 2023. The US Veterinary Artificial Insemination Market Industry is expected to grow from 1.5 (USD Billion) in 2024 to 3 (USD Billion) by 2035. The US Veterinary Artificial Insemination Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035). ### **Key US Veterinary Artificial Insemination Market Trends Highlighted** The US Veterinary Artificial Insemination Market is experiencing notable trends driven by advancements in reproductive technologies and an increasing emphasis on enhancing livestock genetics. Growing awareness among farmers about the benefits of artificial insemination, such as improved breeding efficiency and disease control, is significantly driving demand. The integration of biotechnology, including the development of more effective semen processing techniques and hormonal treatments, is also influencing this market positively. In addition, veterinary services are seeing a shift towards specialized services that support artificial insemination, reflecting a broader trend of precision agriculture in the livestock sector. Opportunities are emerging as the livestock industry faces challenges related to livestock health, productivity, and sustainability. There is a growing interest in genetic improvement and better breeding practices, which can be captured through enhanced artificial insemination techniques. Furthermore, with the rising trend of organic and sustainable farming practices among US producers, the demand for quality breeding options that align with these values is increasing. This presents a unique opportunity for service providers to offer tailored artificial insemination solutions that meet the needs of organic livestock producers. In recent times, the US has seen an uptick in educational programs focused on artificial insemination, enabling breeders to enhance their skills and practice. This trend highlights the importance of workforce development in the field, ensuring that breeders are equipped with the latest knowledge and technologies. Moreover, advancements in digital tools and data analytics are becoming increasingly pertinent, allowing farmers to make informed decisions regarding breeding strategies and efficiently manage their livestock operations. Overall, the convergence of technology, education, and sustainable practices is shaping the future of the veterinary artificial insemination market in the US.  Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Veterinary Artificial Insemination Market Drivers** ### **Growing Demand for Livestock Production** The US [Veterinary Artificial Insemination Market](../../../reports/veterinary-artificial-insemination-market-12359)Industry is experiencing significant growth driven by the increasing demand for livestock products such as meat and dairy. According to the United States Department of Agriculture, the total value of U.S. meat production is projected to grow by 4% over the next decade. This rising demand encourages ranchers and farmers to invest in artificial insemination technologies to enhance the genetics and productivity of their herds. By employing artificial insemination, producers aim to increase the fertility rates and yield superior offspring from high-quality breeds, which ultimately supports the sustainability and economic viability of livestock farming. Furthermore, organizations such as the American Association of Bovine Practitioners emphasize the effectiveness of artificial insemination in improving herd productivity, thus contributing to the booming livestock sector, which is critical to food supply in the US. ### **Technological Advancements in Reproductive Technologies** Recent technological advancements in veterinary reproductive technologies are playing a crucial role in the US Veterinary Artificial Insemination Market Industry. Innovations such as advanced semen freezing technologies and efficient estrus synchronization protocols have improved the success rates of artificial insemination procedures. The National Animal Health Monitoring System has reported that the adoption of these advanced reproductive technologies has increased from 30% to over 50% among dairy producers since 2010. This surge in technology adoption not only enhances breeding efficiency but also supports better management practices within livestock operations. Additionally, the increased accessibility of training programs and workshops by organizations like the American Veterinary Medical Association ensures that more veterinarians are equipped to perform these procedures, thus driving growth in this sector. ### **Rising Awareness of Genetic Improvement in Animals** In the US, there is a growing awareness among livestock producers about the benefits of genetic improvement through artificial insemination. The USDA has reported that producers who utilize artificial insemination can achieve a 15% to 20% increase in the genetic quality of their herds over traditional breeding methods. This heightened awareness is reinforced by industry associations such as the National Dairy Farm Program, which actively promote best practices in genetic management. As farmers recognize the potential for improved milk production, disease resistance, and overall herd health, the demand for artificial insemination services is expected to rise. This trend not only contributes to individual farm productivity but also enhances the overall quality of livestock in the US, laying the groundwork for a more sustainable agricultural framework. ### **Supportive Government Policies and Funding** Supportive government policies and funding initiatives are significantly driving the growth of the US Veterinary Artificial Insemination Market Industry. With incentives for technological upgrades and sustainable agricultural practices, the government encourages farmers to adopt artificial insemination techniques. The USDA's National Institute of Food and Agriculture has allocated millions in grant funding aimed at promoting livestock reproductive technologies, which can help increase market adoption rates. Recently, programs have been introduced that assist farmers in accessing low-interest loans for implementing advanced reproductive technologies, further bolstering the artificial insemination market. This supportive regulatory environment not only helps farmers improve production efficiency but also ensures compliance with evolving animal welfare standards, thus fostering an ecosystem favorable for growth in the US Veterinary Artificial Insemination Market. ## **US Veterinary Artificial Insemination Market Segment Insights** ### **Veterinary Artificial Insemination Market Product Type Insights** The US Veterinary Artificial Insemination Market has seen notable growth in recent years, particularly driven by advancements in technology and increasing awareness among animal breeders about the benefits of artificial insemination techniques. This market is primarily segmented into three product types Equipment, Reagents and Kits, and Others, each playing a significant role in the operational efficiency of artificial insemination practices. Equipment is essential for ensuring proper handling and delivery of sperm, with innovations leading to more effective methods that improve success rates in breeding programs. The importance of high-quality Equipment cannot be overstated, as it not only enhances the overall process but also minimizes the risk of injury to both animals and technicians. Reagents and Kits are key components as well, providing the necessary substances for semen preservation and processing. This segment contributes significantly to the success of artificial insemination through specialized solutions that enhance sperm viability. The focus on developing superior quality reagents indicates a strong trend towards optimizing fertilization success rates and improving reproductive outcomes in livestock. Other products in this market segment serve various other needs and functions, such as training materials and software for breeding management. Trends in the US Veterinary Artificial Insemination Market highlight an increasing demand for more sophisticated and user-friendly products. A growing interest in sustainable farming practices and livestock management has further catalyzed innovations in this area, with many manufacturers focusing on developing solutions that not only boost productivity but also align with environmental considerations. The increasing adoption of artificial insemination by small and large-scale livestock producers showcases a shift in traditional breeding practices, aided by the advantages provided by these product types. As such, understanding the dynamics within the Product Type segment provides valuable insights into the overall landscape of the US Veterinary Artificial Insemination Market. The continuous evolution of Equipment and Reagents reflects the industry's responsiveness to changing market needs and consumer demands, paving the way for significant advancements in veterinary reproductive technology. The support for this technology is further underscored by initiatives aiming to improve animal genetics and overall farm productivity, making these product types indispensable in the veterinary field. In summary, each product type holds equal importance in addressing the challenges faced by the veterinary sector and in promoting more efficient and effective breeding practices across the United States.  Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Veterinary Artificial Insemination Market End User Insights** The US Veterinary Artificial Insemination Market exhibits a diverse range of End Users, primarily including veterinary hospitals, veterinary clinics, and other entities involved in animal reproduction services. Veterinary hospitals take a substantial role, often providing comprehensive reproductive services, including diagnostic procedures, artificial insemination, and post-insemination care. Their extensive facilities and specialized staff contribute to their significance in the market. Meanwhile, veterinary clinics cater to a broader audience, emphasizing preventive care and routine reproductive health, which maintains a steady demand for artificial insemination services. The "others" category encompasses research institutions and agricultural services that require artificial insemination for livestock management, further diversifying the market. The increased awareness of advanced reproductive techniques and the benefits of artificial insemination, such as improved breeding outcomes and genetic diversity, are key growth drivers in this sector. Overall, the focus on animal health, breeding efficiency, and the rising trend of pet ownership and livestock production continue to foster opportunities for growth within the US Veterinary Artificial Insemination Market, driving innovation and investment in various segments. ## **US Veterinary Artificial Insemination Market Key Players and Competitive Insights** The US Veterinary Artificial Insemination Market is characterized by competitive dynamics driven by a growing demand for enhanced reproductive technologies and genetic improvement in livestock and pets. As veterinary practices increasingly shift towards more efficient breeding methods, businesses in this sector are adopting innovative practices to gain an edge. The market comprises a range of players, each striving to establish a significant foothold through strategic initiatives, product diversification, and robust customer relationships. Factors such as advancements in veterinary science, an increase in pet ownership, and rising agricultural productivity are shaping the competitive landscape, leading to an evolving and robust marketplace. Genus is a prominent entity in the US Veterinary Artificial Insemination Market, recognized for its cutting-edge advancements in livestock genetics and breeding solutions. With a strong market presence, Genus leverages its expertise to deliver superior artificial insemination technologies that enhance reproductive efficiency and genetic quality in animals. The company’s strengths lie in its expansive research and development initiatives, which focus on creating genetically superior breeding stock. Genus is known for its strategic partnerships and collaborations, enhancing its distribution channels and customer reach within the veterinary sector. These strategies position Genus favorably to respond to evolving market demands, allowing the company to maintain a competitive edge in the breeding and artificial insemination landscape. Vitro Diagnostics is another key player in the US Veterinary Artificial Insemination Market, noted for its comprehensive range of diagnostic solutions tailored for veterinary practices. The company focuses on providing high-quality products that aid in the evaluation and monitoring of animal reproductive health. With a commitment to innovation, Vitro Diagnostics offers important services such as semen analysis and hormone testing, which are crucial for optimizing artificial insemination processes. The company has established solid market presence through its dedicated service offerings and customer support, ensuring veterinary practitioners have the tools needed for successful artificial insemination. Vitro Diagnostics’ strengths include a well-established reputation for reliability and accuracy, and ongoing efforts in mergers and acquisitions to bolster its product portfolio help the company maintain a prominent position in this competitive market space, particularly focused on advancing reproductive technologies in the United States. ### **Key Companies in the US Veterinary Artificial Insemination Market Include** ## **US Veterinary Artificial Insemination Market Industry Developments** In recent months, the US Veterinary Artificial Insemination Market has seen significant developments, reflecting growth and technological advancements in the sector. Companies such as Genus, Neogen Corporation, and Zoetis are expanding their product lines and services, focusing on enhancing reproductive technologies for livestock and companion animals. In August 2023, Elanco Animal Health announced the acquisition of an innovative startup specializing in genetic solutions for livestock, further consolidating its position in the market. Additionally, Merck Animal Health has launched new veterinary software aimed at improving the efficiency of artificial insemination processes. Amid rising consumer demand for high-quality animal products, the market valuation for this sector is projected to reach significant heights, driven by advancements in artificial insemination techniques and genetics. Major players like Select Sires and STgenetics have also invested in Research and Development, ensuring they remain competitive. Furthermore, the ongoing trend of integration among providers indicates a shifting landscape, with mergers such as the one between Cargill and American Breeders Service in September 2022, solidifying their market presence and capabilities, ultimately influencing the US Veterinary Artificial Insemination Market's dynamics. ## **Veterinary Artificial Insemination Market Segmentation Insights** ### **Veterinary Artificial Insemination Market Product Type Outlook** ### **Veterinary Artificial Insemination Market End User Outlook** ## Market Drivers ### Increased Focus on Animal Welfare this market is increasingly influenced by a heightened focus on animal welfare. Stakeholders, including consumers and regulatory bodies, are advocating for humane treatment and ethical breeding practices. Artificial insemination is perceived as a more humane alternative to natural breeding, reducing stress and potential injury to animals. This shift in consumer preferences is prompting breeders to adopt artificial insemination techniques, thereby expanding the market. Furthermore, the veterinary artificial-insemination market is likely to benefit from the growing awareness of animal welfare issues, as more producers seek to align their practices with ethical standards. ### Growing Awareness of Disease Control this market is significantly impacted by the growing awareness of disease control in livestock populations. Artificial insemination helps mitigate the spread of sexually transmitted diseases among animals, promoting healthier herds. This awareness is particularly crucial in the context of zoonotic diseases, which can have implications for human health. As producers prioritize biosecurity measures, the adoption of artificial insemination is likely to increase. The veterinary artificial-insemination market may see a rise in demand as stakeholders recognize the importance of maintaining herd health and preventing disease outbreaks. ### Rising Demand for Genetic Improvement this market is experiencing a notable surge in demand for genetic improvement among livestock. Farmers and breeders are increasingly seeking to enhance desirable traits such as milk production, growth rates, and disease resistance. This trend is driven by the need for higher productivity and profitability in the agricultural sector. According to recent data, the market for artificial insemination in cattle alone is projected to reach approximately $1.5 billion by 2026, reflecting a compound annual growth rate (CAGR) of around 6%. This growing emphasis on genetic quality is likely to propel the veterinary artificial-insemination market forward, as stakeholders recognize the benefits of utilizing advanced reproductive technologies. ### Economic Benefits of Artificial Insemination The economic benefits associated with the veterinary artificial-insemination market are becoming increasingly apparent to producers. Artificial insemination allows for the efficient use of superior genetics without the need for maintaining multiple breeding males. This not only reduces costs but also enhances the genetic diversity within herds. Producers can achieve higher yields and better quality offspring, leading to increased profitability. Recent studies indicate that farms utilizing artificial insemination can experience a return on investment of up to 300%. As economic pressures mount, this market is likely to gain traction as a cost-effective breeding solution. ### Technological Innovations in Reproductive Techniques Technological innovations are playing a pivotal role in shaping the veterinary artificial-insemination market. Advancements in reproductive technologies, such as cryopreservation and embryo transfer, are enhancing the efficiency and success rates of artificial insemination procedures. These innovations allow for the preservation of genetic material and facilitate the breeding of superior livestock. As a result, this market is expected to witness substantial growth, with estimates suggesting a market value of $2 billion by 2027. The integration of technology into breeding practices is likely to attract more producers, further driving market expansion. ## Future Outlook The [Veterinary Artificial Insemination Market](https://www.marketresearchfuture.com/reports/veterinary-artificial-insemination-market-12359) is projected to grow at a 7.41% CAGR from 2025 to 2035, driven by advancements in reproductive technologies and increasing demand for genetic improvement. **New opportunities:** - Development of mobile AI services for remote veterinary practices. - Integration of AI-driven analytics for breeding success rates. - Expansion of genetic testing services for livestock optimization. By 2035, the market is expected to achieve robust growth, reflecting evolving industry dynamics. ## Segment Insights ### By Type: Equipment (Largest) vs. Reagents & Kits (Fastest-Growing) In the US veterinary artificial-insemination market, the Equipment segment holds the largest share, driven by demand for advanced insemination tools and devices that enhance operational efficiency. Following closely is the Reagents & Kits segment, which has been gaining traction due to the increasing focus on precision and success rates in artificial breeding practices. The Others category, while important, represents a smaller portion of the overall market. Growth trends indicate a robust rise in the Reagents & Kits segment, fueled by innovation in product formulations and heightened awareness of animal reproductive health. Factors such as advancements in reproductive technologies and increasing adoption of artificial insemination in livestock practices are primary drivers. Equipment remains pivotal as it supports these advancements, ensuring that practitioners have access to cutting-edge tools for effective artificial insemination. Equipment (Dominant) vs. Reagents & Kits (Emerging) The Equipment segment is the dominant player in the US veterinary artificial-insemination market, characterized by a wide range of tools including insemination guns, artificial vaginas, and storage containers. Its presence is bolstered by the necessity for reliability and precision in veterinary practices. Conversely, Reagents & Kits are emerging as a vital component, offering comprehensive solutions that include hormonal treatments and diagnostic kits. These products cater to the growing demand for enhanced breeding success rates and are increasingly being integrated into veterinary practices. As technology advances, both segments are set to evolve, with Equipment providing the foundation and Reagents & Kits addressing the specific needs of veterinarians and breeders. ### By End User: Veterinary Hospitals (Largest) vs. Veterinary Clinics (Fastest-Growing) In the US veterinary artificial-insemination market, Veterinary Hospitals hold a significant market share, dominating the landscape due to their comprehensive services and advanced technological capabilities. These facilities offer a wide range of treatments and have established a strong reputation among pet owners, which bolsters their client base. In contrast, Veterinary Clinics, while holding a smaller share, are burgeoning rapidly as they cater to the increasing demand for personalized and accessible veterinary services, making them highly competitive. The growth trends within this segment are influenced by rising pet ownership and the subsequent demand for high-quality veterinary services. Veterinary Clinics are capitalizing on this growth by enhancing their service offerings and adopting innovative practices. Additionally, the convenience factor drives more pet owners to seek services from Clinics as they often provide easier access and affordability compared to larger hospitals, thus marking a significant trend in the market dynamics. Veterinary Hospitals (Dominant) vs. Veterinary Clinics (Emerging) Veterinary Hospitals are recognized as the dominant force in the US veterinary artificial-insemination market, characterized by their operational scale, range of services, and ability to handle complex procedures. They usually possess more advanced technologies and skilled veterinarians, which allows them to offer a broader spectrum of services, including diagnostics and specialized treatments. Conversely, Veterinary Clinics, though emerging, are increasingly focusing on providing more personalized care and flexible solutions, appealing to a more local and often budget-conscious clientele. The rapid expansion of Veterinary Clinics reflects changing consumer preferences toward convenience, driving the shift in market dynamics as they innovate their service delivery and improve patient engagement. ## Competitive Benchmarking The veterinary artificial-insemination market is characterized by a dynamic competitive landscape, driven by advancements in reproductive technologies and increasing demand for genetic improvement in livestock. Key players such as Zoetis Inc. (US), Merck Animal Health (US), and Genus plc (GB) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Zoetis Inc. (US) focuses on integrating digital solutions into its offerings, while Merck Animal Health (US) emphasizes research and development to expand its product portfolio. Genus plc (GB) is actively pursuing global expansion, particularly in emerging markets, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic collaborations. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Zoetis Inc. (US) and Merck Animal Health (US) suggests a trend towards consolidation, as these firms seek to strengthen their competitive positions through strategic acquisitions and partnerships. In October 2025, Zoetis Inc. (US) announced a partnership with a leading agricultural technology firm to develop an AI-driven platform aimed at improving the efficiency of artificial insemination processes. This strategic move is likely to enhance Zoetis's product offerings and position it as a leader in the integration of technology within the veterinary sector. The collaboration underscores the growing importance of digital solutions in optimizing reproductive outcomes and reflects a broader trend towards innovation in the market. In September 2025, Merck Animal Health (US) launched a new line of reproductive health products designed specifically for dairy cattle. This introduction is significant as it addresses the increasing demand for high-quality genetic material and reproductive efficiency in the dairy industry. By expanding its product range, Merck aims to capture a larger share of the market and respond to the evolving needs of livestock producers. In August 2025, Genus plc (GB) completed the acquisition of a regional player specializing in artificial insemination technologies. This acquisition is indicative of Genus's strategy to enhance its technological capabilities and expand its geographic footprint. By integrating the acquired company's expertise, Genus is likely to strengthen its competitive edge and offer more comprehensive solutions to its customers. As of November 2025, current trends in the veterinary artificial-insemination market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on technology and supply chain reliability rather than solely on price. This shift suggests that companies that prioritize innovation and adaptability will likely emerge as leaders in the market. ## Recent News & Developments In recent months, the US Veterinary Artificial Insemination Market has seen significant developments, reflecting growth and technological advancements in the sector. Companies such as Genus, Neogen Corporation, and Zoetis are expanding their product lines and services, focusing on enhancing reproductive technologies for livestock and companion animals. In August 2023, Elanco Animal Health announced the acquisition of an innovative startup specializing in genetic solutions for livestock, further consolidating its position in the market. Additionally, Merck Animal Health has launched new veterinary software aimed at improving the efficiency of artificial insemination processes. Amid rising consumer demand for high-quality animal products, the market valuation for this sector is projected to reach significant heights, driven by advancements in artificial insemination techniques and genetics. Major players like Select Sires and STgenetics have also invested in Research and Development, ensuring they remain competitive. Furthermore, the ongoing trend of integration among providers indicates a shifting landscape, with mergers such as the one between Cargill and American Breeders Service in September 2022, solidifying their market presence and capabilities, ultimately influencing the US Veterinary Artificial Insemination Market's dynamics. ## Report Scope | MARKET SIZE 2024 | 1334.23(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1433.1(USD Million) | | MARKET SIZE 2035 | 2929.24(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.41% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Genus plc (GB), Zoetis Inc. (US), Merck Animal Health (US), Heska Corporation (US), Neogen Corporation (US), CooperSurgical Inc. (US), Vetoquinol S.A. (FR), Boehringer Ingelheim (DE), Allflex Livestock Intelligence (AU) | | Segments Covered | Type, End User | | Key Market Opportunities | Advancements in reproductive technologies enhance efficiency in the veterinary artificial-insemination market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the veterinary artificial-insemination market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US veterinary artificial-insemination market in 2024?** A: The market valuation was $1334.23 Million in 2024. **Q: What is the projected market valuation for the US veterinary artificial-insemination market by 2035?** A: The projected valuation for 2035 is $2929.24 Million. **Q: What is the expected CAGR for the US veterinary artificial-insemination market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 7.41%. **Q: Which segments contributed to the US veterinary artificial-insemination market's performance?** A: Key segments include Equipment, Reagents & Kits, and Others, with valuations ranging from $334.23 Million to $1300 Million. **Q: Who are the key players in the US veterinary artificial-insemination market?** A: Key players include Genus plc, Zoetis Inc., Merck Animal Health, and Heska Corporation, among others. **Q: What was the valuation of the Equipment segment in the US veterinary artificial-insemination market in 2024?** A: The Equipment segment was valued at $400 Million in 2024. **Q: What is the projected valuation for the Reagents & Kits segment by 2035?** A: The projected valuation for the Reagents & Kits segment is $1300 Million by 2035. **Q: How did the Veterinary Clinics segment perform in 2024?** A: The Veterinary Clinics segment was valued at $600 Million in 2024. **Q: What is the expected growth trend for the Others segment in the US veterinary artificial-insemination market?** A: The Others segment is expected to grow from $334.23 Million in 2024 to $779.24 Million by 2035. **Q: What role do companies like Boehringer Ingelheim play in the US veterinary artificial-insemination market?** A: Companies like Boehringer Ingelheim contribute to market leadership and innovation within the sector. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-veterinary-artificial-insemination-market-16668*